Coreline Soft Aligns with Germany's New Lung Cancer Reimbursement Framework

Germany is implementing a national lung cancer screening program as the Federal Joint Committee approves low-dose computed tomography (LDCT) for high-risk individuals. As of April 1, 2026, eight new services will receive extra-budgetary reimbursement, marking a shift to a process- and operations-driven model. The initiative covers the entire screening workflow, requiring hospitals to meet and bill for comprehensive organizational, qualitative, and clinical criteria.

Coreline Soft is expanding its market presence with operational AI solutions like AVIEW LCS and AVIEW HUB. These tools support multi-center collaboration and structured reporting. The focus is on seamless integration with existing healthcare IT systems to meet data protection and standardization needs under GDPR regulations. This initiative highlights the company's technological strength and its solutions' use in renowned medical institutions.